Stephanie Wenstrup
Director, CVMD
AstraZeneca
Stephanie is currently the consumer lead for the cardiovascular and diabetes brands at AstraZeneca. Over the past year, she has launched the first national DTC campaign for Brilinta, continued to build awareness and equity in Farxiga with the launch of the “Pill that Starts with F” campaign, and most recently, launched a strong DTC campaign for the diabetes product, Bydureon BCise. Prior to joining AstraZeneca, she worked at Bristol Myers Squibb, Johnson and Johnson, and Wyeth, where she launched various diabetes and specialty products.
Stephanie has over 18 years of experience in marketing and consulting in the pharmaceutical, medical device and hospital industries. She has extensive experience in U.S. and global product launches, new product development, data analytics, and global strategic management. Stephanie has a B.A. from Washington & Lee University and an M.B.A. from Cornell University. Stephanie lives in Wayne, PA with her three children and stubborn bulldog, Gunnar.
